Advanced search
Publication Cover
Journal of Blood Medicine Volume 10, 2019 - Issue
Submit an article Journal homepage
78
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Serum high mobility group box protein 1 (HMGB1) levels reflect clinical features of childhood hemophagocytic lymphohistiocytosis

Hiroshi TsujimotoDepartment of Pediatrics, Wakayama Medical University, Wakayama, JapanCorrespondence[email protected]
,
Shinji KounamiDepartment of Pediatrics, Wakayama Medical University, Wakayama, Japan
,
Takayuki IchikawaDepartment of Pediatrics, Wakayama Medical University, Wakayama, Japan
,
Taketsugu HamaDepartment of Pediatrics, Wakayama Medical University, Wakayama, Japan
&
Hiroyuki SuzukiDepartment of Pediatrics, Wakayama Medical University, Wakayama, Japan
Pages 301-306 | Published online: 27 Aug 2019

References

  • Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol. 2013;93(6):865–873. doi:10.1189/jlb.121266223446148
  • Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018;38:40–48. doi:10.1016/j.smim.2018.02.01129530410
  • Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–251. doi:10.1126/science.285.5425.24810398600
  • Martinotti S, Patrone M, Ranzato E. Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther. 2015;4:101–109.27471716
  • Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int. 2016;58(9):817–825. doi:10.1111/ped.1279027289085
  • Brisse E, Wouters C, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol. 2016;174(2):203–217. doi:10.1111/bjh.1408427264204
  • Alcamo AM, Pang D, Bashir DA, et al. Role of damage-associated molecular patterns and uncontrolled inflammation in pediatric sepsis-induced multiple organ dysfunction syndrome. J Pediatr Intensive Care. 2019;8(1):25–31. doi:10.1055/s-0038-167563931073505
  • Palmblad K, Schierbeck H, Sundberg E, et al. High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome. Mol Med. 2014;20(1):538–547. doi:10.2119/molmed.2014.00183
  • Wang DJ, Wang JJ, Song M, et al. Expression of serum HMGB-1 in patients with secondary hemophagocytic lymphohistiocytosis and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24(3):878–883.27342526
  • Farias-Moeller R, LaFrance-Corey R, Bartolini L, et al. Fueling the FIRES: hemophagocytic lymphohistiocytosis in febrile infection-related epilepsy syndrome. Epilepsia. 2018;59(9):1753–1763. doi:10.1111/epi.1452430132834
  • Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131. doi:10.1002/pbc.2103916937360
  • Wada H, Gabazza EC, Asakura H, et al. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the international society of thrombosis and hemostasis (ISTH) and of the Japanese ministry of health and welfare for overt DIC. Am J Hematol. 2003;74(1):17–22. doi:10.1002/ajh.1037712949885
  • Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi:10.1038/bmt.2012.24423208313
  • Lehmberg K, Nichols K, Henter JI, et al. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica. 2015;100(8):997–1004.26314082
  • Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Ann Rev Immunol. 2011;29:139–162. doi:10.1146/annurev-immunol-030409-10132321219181
  • Brisse E, Matthys P, Wouters C. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol. 2016;174(2):175–187. doi:10.1111/bjh.1408427292929
  • Valade S, Azoulay E, Galicier L, et al. Coagulation disorders and bleeding in critically ill patients with hemophagocytic lymphohistiocytosis. Medicine. 2015;94(40):e1692. doi:10.1097/MD.000000000000169226448017
  • Horne A, Trottestam H, Aricò M, et al. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2007;140(3):327–335. doi:10.1111/j.1365-2141.2007.06922.x18076710
  • Liaw PC, Ito T, Iba T, et al. DAMP and DIC: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. Blood Rev. 2016;30(4):257–261. doi:10.1016/j.blre.2015.12.00426776504
  • Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol. 1992;9(1):63–74.1561489
  • Yang SL, Xu XJ, Tang YM, et al. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis. Cytokine. 2016;85:14–17. doi:10.1016/j.cyto.2016.05.02227269180
  • Sankowski R, Mader S, Valdés-Ferrer SI. Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015;9:28. doi:10.3389/fncel.2015.0002825698933

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.